article thumbnail

Our Best of 2018- to Fuel Your Best 2019

Integrity Solutions

Here is some of our ‘Best of 2018’ content that can help fuel thoughts, discussions and strategies to make 2019 your best year yet. Our most-read blog of 2018 was this one by Joyce Hames. As 2018 comes to a close we reflect back on a great year and look optimistically at the year to come.

article thumbnail

Eli Lilly agrees to provide free and lower-priced insulin in Minnesota to resolve 2018 lawsuit

Fierce Pharma

After reaching a settlement with Minnesota’s attorney general, Eli Lilly can close the book on a yearslong lawsuit in the state. | The company will provide its insulin products at $35 per month and donate free insulin at 15 clinics over the next five years. Meanwhile, Minnesota's claims against Novo Nordisk and Sanofi remain ongoing.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO flags increasing resistance to GSK's HIV med Tivicay in some countries

Fierce Pharma

GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization since 2018 as a preferred treatment for the virus. |

Medicine 287
article thumbnail

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

The lawsuit further accuses the companies of manipulating quality-control testing from 2012 to 2018 to ensure samples received passing grades. . | In its lawsuit, Texas says the companies knew that deficient manufacturing processes compromised the effectiveness of Quillivant XR.

article thumbnail

Racial disparities in maternal health complications grew amid Covid-19, BCBS report finds

MedCity News

Pregnancy-related complications increased 9% between 2018 and 2020 among all women, but the rate of change is even more significant among women of color. The disparities exist regardless of having commercial insurance or Medicaid.

Insurance 290
article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

FDA 298
article thumbnail

Redesign Health Raises $175M to Create Dozens More Startups 

MedCity News

The company has already created more than 60 startups since its launch in 2018. Redesign Health closed a $175 million investment round that will fuel the creation of more healthcare startups. The post Redesign Health Raises $175M to Create Dozens More Startups appeared first on MedCity News.